Medtronic recalls Paradigm insulin pumps (MMT-712, MMT-715) that may deliver incorrect insulin doses if moved up or down from the body, risking life-threatening blood sugar issues.
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Medtronic is recalling Paradigm insulin pumps (MMT-712 and MMT-715 models) because moving the pump higher or lower than the injection site can cause incorrect insulin delivery. This may lead to severe low blood sugar (hypo) or high blood sugar (hyper) conditions that could be life-threatening.
When the pump is elevated above the injection site, it can deliver too much insulin, causing severe low blood sugar that might lead to coma or death. When the pump is lowered below the injection site, it can deliver too little insulin, causing severe high blood sugar that might lead to dehydration or diabetic ketoacidosis.
People using Medtronic Paradigm insulin pumps (MMT-712 and MMT-715 models) are affected. Those with diabetes who rely on these pumps for insulin delivery are most at risk.
Check for the pump model numbers MMT-712 or MMT-715. These pumps were sold with specific part numbers listed in the recall notice. The product names include 'Paradigm Insulin Pump' with the UDI-DI codes provided.
Discontinue use of the Paradigm insulin pump (MMT-712 or MMT-715) if you have it.
The affected models are Paradigm insulin pumps with part numbers MMT-712 and MMT-715, as listed in the recall notice.
Moving the pump higher than the injection site can cause too much insulin delivery, risking severe low blood sugar. Moving it lower can cause too little insulin delivery, risking severe high blood sugar.
The recall record does not mention any remedy or fix for this issue.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-1748-2026 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-1748-2026 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
